Search

everythinglearnresearchcommunity

for

Search:↓

Plant adaptogens may help treat skin diseases and improve skin health, but more research is needed to fully understand how they work.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Curcuma aeruginosa Roxb. may help treat hair loss by affecting specific biological pathways.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Different types of resting melanocyte stem cells have unique characteristics and vary in their potential to become other cells.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Iris germanica rhizome-derived exosomes help protect skin cells from oxidative stress and aging.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

New ginseng compounds may help treat degenerative diseases.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

Olfactory receptors found outside the nose may offer new treatments for diseases like cancer and help in wound healing and hair growth.

PRP is a promising treatment for autoimmune hair loss but its exact workings are not fully understood.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Skin cells and immune cells change in a skin condition called hidradenitis suppurativa, and a certain treatment can improve these changes.

The conclusion is that healthcare professionals should report adverse drug reactions to improve medication safety and patient care.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.